Model N

Our #ModelN'ers are making the most of summer with travel, time with family and friends, hiking, beach days, and new adventures. We're glad to see everyone taking time to relax, recharge, and enjoy the moments that matter most. ☀️ #ModelNLife #NFactor

With 85% of medtech revenue from tenders, strong tendering capabilities are critical to protecting market access and profitability. To succeed in this complex and changing environment, it’s time to rethink your approaches, practices, and initiatives. Discover how leading medtech companies are winning more bids with an integrated approach: https://lnkd.in/g_5KC6e8 #ModelN #Medtech

Three-quarters of medtech companies still operate with siloed data, which means slower decisions and missed revenue opportunities. The medtech leaders pulling ahead in 2026 are building integrated revenue ecosystems. Learn what separates them in Model N's 2026 State of Revenue Report: https://lnkd.in/gRxN2pA5 #ModelN #MedTech

Missed deadlines. Calculation errors. Information silos. When government pricing rules evolve, you shouldn't be stuck in manual workflows. The Model N regulatory compliance suite delivers automated calculations, real-time updates, and built-in audit trails, so you can minimize risk of non-compliance and protect your revenue. Learn more ➡️ https://lnkd.in/g8xG-eAW #ModelN #LifeSciences #Pharma #RevenueOptimization #Compliance

Your organization pays rebates, then chases recovery. But when 80-90% of overpayments never come back, the system itself is broken. Formulary compliance doesn't have to be reactive. In this blog by Jeffrey Albright, learn how leading #pharma companies are moving from pay-and-chase to proactive compliance management: https://lnkd.in/gf483E6G #ModelN #LifeSciences 

Swaraj Shekhar joined Model N 11 years ago, and his journey to becoming a software architect speaks volumes about his commitment to the company. "Moving the company forward is what keeps me energized every day," Swaraj shares. We're grateful for his growth, his impact, and the energy he brings to the team. #ModelN #ModelNLife #NFactor

More than half of new drugs fail to achieve their first-year revenue targets. Today's launches span more markets, involve more stakeholders, and face greater scrutiny, but many teams still rely on spreadsheets and email-driven workflows. When execution becomes fragmented, pricing strategy breaks. Leading organizations are connecting launch strategy to execution with consolidated systems that enable real-time collaboration across global and local teams. Learn how in this blog by Bernard Gutierrez: https://lnkd.in/gN2p2Nbu #ModelN #LifeSciences

When a European-based global healthcare organization implemented Model N Global Tender Management, tenders grew from 20% to over 30% of revenue. By replacing fragmented Excel spreadsheets with a centralized platform, they enabled faster approvals, better visibility, and more confident tender participation. Learn more: https://lnkd.in/gy5dEQqz #ModelN #Pharma #LifeSciences

The need for GTN oversight is reshaping how pharma manufacturers manage financial exposure, compliance, and decisions. The shift to greater claims-level visibility across 340B and beyond is essential. Watch this webinar with Daniel Golder to understand the shift and what it means for your organization: https://lnkd.in/ggnfBJNR #ModelN #LifeSciences #Pharma #340B

Pharma manufacturers: The IRA is here and it's complex. Get the essential guide to understanding regulatory and operational changes, assess the IRA's impact on your business, and develop effective strategies for navigating this new landscape. Read now: https://lnkd.in/d-FCAu9b #ModelN #LifeSciences #Pharma